• Thyroid Stimulating Immunoglobulin (TSI)
  • Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
  • Bladder Tumor Antigen (BTA)
  • MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
  • Iron, Serum
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • HER2/neu (ERBB2) Gene Amplification, FISH, Urothelial Carcinoma
  • Human Growth Hormone (Somatotropin)
  • Ehrlichia chaffeensis and Anaplasma Species by Real-Time PCR
  • Legionella pneumophila Antibody, IgG by IFA
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MSK-IMPACT™, Solid Organ Gene Cancer Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MSK-IMPACT™, Solid Organ Gene Cancer Panel
Medical Test

Clinical Utility
Access to MSK-IMPACT™, Solid Organ Gene Cancer Panel is restricted.